The bone-seeking property and the potential exposure of red marrow by the -particle emitter 223Ra (half-life, 11.43 d) were compared with those of the -emitter 89Sr (half-life, 50.53 d). Methods: The biodistributions of 223Ra and 89Sr were studied in mice. Tissue uptake was determined at 1 h, 6 h, 1 d, 3 d, and 14 d after intravenous administration. Radiation absorbed doses were calculated for soft tissues and for bone. Multicellu-lar-level doses were estimated for bone marrow cavities. Re-sults: Both 89Sr and 223Ra selectively concentrated on bone surfaces relative to soft tissues. The measured bone uptake of 223Ra was slightly higher than that of 89Sr. At 24 h, the femur uptake of 223Ra was 40.1 % 7.7 % of the administered activity per ...
Various single or multi-modality therapeutic options are available to treat pain of bone metastasis ...
ABSTRACT: Bone-seeking radionuclides including samarium-153 ethylene diamine tetramethylene phosphon...
Radionuclide therapy with 223Ra-dichloride is used to treat bone metastases and to improve the quali...
The therapeutic efficacy of the -particle-emitting radionuclide 223Ra (t1/2 11.4 days) in the treat...
The distribution of intraperitonally-injected 224Ra was studied in NMRI mice and WISTAR rats. The hi...
227Th is an interesting model for a short-lived bone 'surface-seeker' with αemission. ...
Alpha-particle-emitting radionuclides have potential for therapy of localized disease due to their h...
224Ra (half-life 3.64 days) or 227Th (half-life 18.7 days) were intraperitoneally injected in 3-4 we...
224Ra was applied with one single injection or with repeated injections (twice weekly over various t...
The examinations on early damage on the skeleton were carried out in the proximal fibia metaphysis o...
[\(^{223}\)Ra]RaCl\(_2\) and [\(^{224}\)Ra]RaCl\(_2\) are bone seekers, emitting high LET, and short...
Single and repeated applications of 224Ra and single applications of 227Th to more than 600 female N...
have been used to treat bone pain. The limiting factor in this modality is marrow toxicity. Our hypo...
224Ra as a short-lived boneseeker is an important substance in medicine as well as in biology. Unsys...
Osteocytes from the proximal tibial metaphysis of mice were examined by electron microscopy at vario...
Various single or multi-modality therapeutic options are available to treat pain of bone metastasis ...
ABSTRACT: Bone-seeking radionuclides including samarium-153 ethylene diamine tetramethylene phosphon...
Radionuclide therapy with 223Ra-dichloride is used to treat bone metastases and to improve the quali...
The therapeutic efficacy of the -particle-emitting radionuclide 223Ra (t1/2 11.4 days) in the treat...
The distribution of intraperitonally-injected 224Ra was studied in NMRI mice and WISTAR rats. The hi...
227Th is an interesting model for a short-lived bone 'surface-seeker' with αemission. ...
Alpha-particle-emitting radionuclides have potential for therapy of localized disease due to their h...
224Ra (half-life 3.64 days) or 227Th (half-life 18.7 days) were intraperitoneally injected in 3-4 we...
224Ra was applied with one single injection or with repeated injections (twice weekly over various t...
The examinations on early damage on the skeleton were carried out in the proximal fibia metaphysis o...
[\(^{223}\)Ra]RaCl\(_2\) and [\(^{224}\)Ra]RaCl\(_2\) are bone seekers, emitting high LET, and short...
Single and repeated applications of 224Ra and single applications of 227Th to more than 600 female N...
have been used to treat bone pain. The limiting factor in this modality is marrow toxicity. Our hypo...
224Ra as a short-lived boneseeker is an important substance in medicine as well as in biology. Unsys...
Osteocytes from the proximal tibial metaphysis of mice were examined by electron microscopy at vario...
Various single or multi-modality therapeutic options are available to treat pain of bone metastasis ...
ABSTRACT: Bone-seeking radionuclides including samarium-153 ethylene diamine tetramethylene phosphon...
Radionuclide therapy with 223Ra-dichloride is used to treat bone metastases and to improve the quali...